Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016–2018 season

International Journal of Infectious Diseases

Ching-Yuan Yeh¹  Wang-Da Liu²  Ming-Chieh Shih²  Wang-Huei Sheng³ 

[1] Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan;Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan;

关键词: Influenza A;    Influenza B;    Liver cirrhosis;    Severe influenza;    Risk factor;   

DOI  :  

来源: DOAJ

【 摘 要 】

Objectives: Influenza remains a crucial transmissible disease from community. We aim to identify risk factors associated with mortality among hospitalized patients with severe influenza. Methods: We retrospectively reviewed medical records of adult patients with laboratory-confirmed severe influenza at a medical center between January 2016 and December 2018. The primary outcome was 30-day all-cause mortality. Results: Totally 96 patients were enrolled, with 73 patients in the influenza A group and 23 in the influenza B group. Eighteen (18.8%) deaths occurred within 30 days of hospitalization, including 8 (11%) and 10 (43.5%) of each group. In multivariable Cox regression analysis, factors associated with mortality were underlying diseases of liver cirrhosis (adjusted hazard ratio [AHR], 3.94; 95% CI, 1.07–14.45) and rheumatologic diseases (AHR, 7.45; 95% CI, 2.34–23.69) and the diagnosis of influenza B (AHR, 4.33; 95% CI, 1.68–11.13). Conclusions: Clinician should early identify high-risk population and warning signs of severe influenza. Our results support the policy of quadrivalent influenza vaccination because influenza B could be associated with high mortality.

【 授权许可】

Unknown